Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(0.19)
# 4,885
Out of 5,182 analysts
25
Total ratings
18.18%
Success rate
-26.96%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Maintains: Overweight | $270 → $255 | $177.25 | +43.86% | 2 | Apr 23, 2026 | |
| MMED MiniMed Group | Initiates: Overweight | $19 | $13.20 | +43.94% | 1 | Mar 31, 2026 | |
| A Agilent Technologies | Maintains: Overweight | $180 → $160 | $115.55 | +38.47% | 2 | Mar 3, 2026 | |
| WAT Waters | Maintains: Equal-Weight | $423 → $350 | $309.87 | +12.95% | 2 | Feb 23, 2026 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,550 → $1,475 | $1,282.45 | +15.01% | 2 | Feb 10, 2026 | |
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $285 | $306.16 | -6.91% | 1 | Dec 2, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $105 → $130 | $56.31 | +130.86% | 7 | Dec 2, 2025 | |
| PEN Penumbra | Maintains: Equal-Weight | $260 → $266 | $329.89 | -19.37% | 8 | Jul 31, 2025 |
Danaher
Apr 23, 2026
Maintains: Overweight
Price Target: $270 → $255
Current: $177.25
Upside: +43.86%
MiniMed Group
Mar 31, 2026
Initiates: Overweight
Price Target: $19
Current: $13.20
Upside: +43.94%
Agilent Technologies
Mar 3, 2026
Maintains: Overweight
Price Target: $180 → $160
Current: $115.55
Upside: +38.47%
Waters
Feb 23, 2026
Maintains: Equal-Weight
Price Target: $423 → $350
Current: $309.87
Upside: +12.95%
Mettler-Toledo International
Feb 10, 2026
Maintains: Equal-Weight
Price Target: $1,550 → $1,475
Current: $1,282.45
Upside: +15.01%
West Pharmaceutical Services
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $285
Current: $306.16
Upside: -6.91%
Inspire Medical Systems
Dec 2, 2025
Downgrades: Equal-Weight
Price Target: $105 → $130
Current: $56.31
Upside: +130.86%
Penumbra
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $260 → $266
Current: $329.89
Upside: -19.37%